Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 Penumbra Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2021 / 03:00PM GMT
Release Date Price:
€241
(+2.29%)
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
Good morning, and thank you for joining us for the fourth day of the 2021 Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, medical device analyst and a member of the health care research team here at Morgan Stanley. It's my pleasure to have Penumbra with us today, Adam Elsesser, President and CEO. And before we begin, I'll run through our disclaimer for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to Morgan Stanley sales representative. With that, Adam, thank you for joining us today.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. Thanks for having us, Cecilia.
Questions & Answers
Cecilia E. Furlong
Morgan Stanley, Research Division - Equity Analyst
I wanted to start off with 2021,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot